article thumbnail

Summing up the STAR*D Scandal: The Public was Betrayed, Millions were Harmed, and the Mainstream Media Failed Us All

Mad in America

As such, the scandal now serves as a historical verdict on the ethics of American psychiatry, and by extension, the National Institute of Mental Health (NIMH). In 2006, the American Journal of Psychiatry (AJP) published four reports on STAR*D outcomes. There was one other red flag.

article thumbnail

Depression: Psychiatry’s Discredited Theories and Drugs Versus a Sane Model and Approach

Mad in America

In summary, researchers have found no serotonin nor any other neurotransmitter association with depression, no neurobiological associations, and no genetic associations. They justify this with the 2006 reported results of the NIMH-funded “ Sequenced Treatment Alternatives to Relieve Depression (STAR*D). But What If It’s Broken?”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Winding Back the Clock: What If the STAR*D Investigators Had Told the Truth?

Mad in America

Here is the cover from that issue: In his essay, Miller repeatedly stressed that ever since 2006, the STAR*D study had stood “out as a beacon guiding treatment decisions.” Two years later, in a National Institute of Health study that compared Zoloft to St. Prozac, a psychiatrist told The New York Times , “is not like alcohol or Valium.

article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. This applies in the mental illness world and everywhere in medicine. It was a fun thing to do, and we launched it in the British Medical Journal on April 1 st , 2006. I started writing books.